Detrimental Role of CC Chemokine Receptor 4 in Murine Polymicrobial Sepsis
-
Published:2008-11
Issue:11
Volume:76
Page:5285-5293
-
ISSN:0019-9567
-
Container-title:Infection and Immunity
-
language:en
-
Short-container-title:Infect Immun
Author:
Traeger Tobias1, Kessler Wolfram1, Assfalg Volker2, Cziupka Katharina1, Koerner Pia1, Dassow Constanze1, Breitbach Katrin3, Mikulcak Marlene1, Steinmetz Ivo3, Pfeffer Klaus4, Heidecke Claus-Dieter1, Maier Stefan1
Affiliation:
1. Department of Surgery, Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Germany 2. Department of Surgery, Technische Universität München, Munich, Germany 3. Friedrich-Loeffler-Institute of Medical Microbiology, Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Germany 4. Institute of Medical Microbiology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
Abstract
ABSTRACT
CC chemokine receptor 4 (CCR4) and its two ligands, CCL17 and CCL22, are critically involved in different immune processes. In models of lipopolysaccharide-induced shock, CCR4-deficient (CCR4
−/−
) mice showed improved survival rates associated with attenuated proinflammatory cytokine release. Using CCR4
−/−
mice with a C57BL/6 background, this study describes for the first time the role of CCR4 in a murine model of polymicrobial abdominal sepsis, the colon ascendens stent peritonitis (CASP). CASP-induced sepsis led to a massive downregulation of CCR4 in lymphoid and nonlymphoid tissues, whereas the expression of CCL17 and CCL22 was independent of the presence of CCR4. After CASP, CCR4
−/−
animals showed a strongly enhanced bacterial clearance in several organs but not in the peritoneal lavage fluid and the blood. In addition, significantly reduced levels of proinflammatory cytokines/chemokines were measured in organ supernatants as well as in the sera of CCR4
−/−
mice. CCR4 deficiency consequently resulted in an attenuated severity of systemic sepsis and a strongly improved survival rate after CASP or CASP with intervention. Thus, our data provide clear evidence that CCR4 plays a strictly detrimental role in the course of polymicrobial sepsis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference70 articles.
1. Abraham, E. 1999. Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med.25:556-566. 2. Abraham, E., A. Anzueto, G. Gutierrez, S. Tessler, G. San Pedro, R. Wunderink, A. Dal Nogare, S. Nasraway, S. Berman, R. Cooney, H. Levy, R. Baughman, M. Rumbak, R. B. Light, L. Poole, R. Allred, J. Constant, J. Pennington, S. Porter, et al. 1998. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet351:929-933. 3. Abraham, E., M. P. Glauser, T. Butler, J. Garbino, D. Gelmont, P. F. Laterre, K. Kudsk, H. A. Bruining, C. Otto, E. Tobin, C. Zwingelstein, W. Lesslauer, A. Leighton, et al. 1997. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. JAMA277:1531-1538. 4. Andrew, D. P., M. S. Chang, J. McNinch, S. T. Wathen, M. Rihanek, J. Tseng, J. P. Spellberg, and C. G. Elias III. 1998. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol.161:5027-5038. 5. Baatar, D., P. Olkhanud, D. Newton, K. Sumitomo, and A. Biragyn. 2007. CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors. J. Immunol.179:1996-2004.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|